KAPA vs SPCE · $18.8M cap vs rev $361.0K
Kairos Pharma, Ltd. (KAPA) versus Virgin Galactic Holdings Inc (SPCE) — a side-by-side from cached financials, not a winner call.
Kairos Pharma, Ltd. (KAPA) is a biotechnology company listed on US.
Virgin Galactic Holdings Inc (SPCE) is a aerospace & defense company listed on NYSE.
KAPA does not have a complete income-statement cache yet.
Latest reported SPCE revenue for 2026-06-30 was $361.0K. Net income was -$120.6M. Revenue was up 59.0% from 2026-03-31 to 2026-06-30. SPCE currently screens at market cap $388.0M.
KAPA currently screens at market cap $18.8M. SPCE currently screens at market cap $388.0M.
Not investment advice. Open the KAPA and SPCE stock pages for the full models.
Not investment advice.